Patients living with chronic diseases frequently endure the burden of taking multiple medications. The ensuing polypharmacy leads to reduced adherence, increased risk of adverse effects and impairment of quality of life due to pill burden. Yet, as the patient approaches end of life and prognosis becomes limited, some medications may no longer be beneficial and “when lesser may be better”.
A palliative care approach, which seeks to improve the quality of life of patients and their families facing life-threatening illness, can help balance between chronic disease management and optimal quality life by aligning treatment with patient’s prognosis and goals of care. Having an understanding of the principles for de-prescribing in palliative care will help pharmacists enhance care and improve quality of life for patients facing life-limiting illnesses.
This lecture will review the principles and considerations behind de-prescribing in palliative care, and illustrate how pharmacists can work with clinical teams to rationalize chronic disease medications.
Click here for more lecture details.
To register, scan the QR code or click on the web link. Registration closes on 7 October 2020, Wednesday.
By registering, participant has agreed to PGAHI Terms & Conditions.
Date:21 October 2020, Wednesday
Timing:6.30 pm - 7.30 pm
Platform:Zoom Cloud Meetings
Registration Closing Date:7 October 2020, Wednesday
This lecture will be conducted via Zoom Cloud Meetings app. For ease of accessing the lecture, please download/update Zoom Cloud Meetings app. Details of the lecture meeting link will be sent to the successful registrants nearer the lecture date.